M90.629 Osteitis deformans in neoplastic diseases, unspecified upper arm

Name of the Condition

• Osteitis deformans in neoplastic diseases, unspecified upper arm

Summary

Osteitis deformans in neoplastic diseases, unspecified upper arm (ICD Code M90.629) refers to a bone disorder characterized by abnormal bone remodeling, occurring as a secondary manifestation of underlying neoplastic (cancerous) conditions. This condition involves structural changes in bone tissue due to the effects of malignancies on bone metabolism or structure, specifically affecting the upper arm region without further specification.

Causes

The causes of osteitis deformans in neoplastic diseases are directly linked to the presence of cancer. Malignancies, such as primary bone tumors or metastatic cancer, can disrupt normal bone turnover, leading to excessive bone resorption and formation. This imbalance results in the characteristic deformities and structural changes associated with the condition in the upper arm.

Risk Factors

• Malignancies (primary or metastatic) involving the upper arm
• Cancers affecting bone metabolism (e.g., breast, prostate, lung cancer)
• Prior radiation therapy to the upper arm
• Advanced-stage cancer
• Chronic inflammatory conditions associated with cancer

Symptoms

• Bone pain or tenderness in the upper arm
• Skeletal deformities (e.g., bowing of the humerus)
• Increased risk of fractures in the upper arm
• Joint stiffness or swelling around the shoulder or elbow
• Reduced mobility or function of the upper arm

Diagnosis

Diagnosis involves correlating clinical findings with the underlying neoplastic disease. Imaging (X-rays, MRI, or CT) assesses bone changes, while laboratory tests may evaluate bone turnover markers or detect cancer-related abnormalities. A thorough review of the patient’s medical history and cancer diagnosis is essential to confirm the condition.

Treatment Options

Treatment focuses on managing the underlying neoplastic disease and addressing bone-related symptoms. This may include cancer therapies (chemotherapy, radiation, or surgery), pain management, physical therapy to maintain mobility, and medications to stabilize bone structure (e.g., bisphosphonates). Surgical intervention may be considered for severe deformities or fractures.

Prognosis and Follow-Up

Prognosis depends on the type and stage of the underlying cancer and the extent of bone involvement. Regular follow-up is necessary to monitor disease progression, bone health, and treatment response. Long-term management may involve ongoing imaging and functional assessments to address complications like fractures or deformities.

Complications

• Pathologic fractures of the upper arm
• Progressive bone deformities affecting arm function
• Chronic pain or disability
• Impaired mobility or range of motion
• Potential spread of neoplastic disease to other areas

Lifestyle & Prevention

Lifestyle modifications may support bone health, such as maintaining a balanced diet rich in calcium and vitamin D, engaging in gentle exercise to preserve strength, and avoiding activities that increase fracture risk. Prevention focuses on managing the underlying cancer and its effects on bone metabolism.

When to Seek Professional Help

Seek medical attention if you experience persistent bone pain, swelling, or deformity in the upper arm, especially if you have a history of cancer. Prompt evaluation is important to address potential fractures or worsening bone changes.

Tips for Medical Coders

When coding M90.629, ensure the documentation specifies the condition as osteitis deformans secondary to neoplastic diseases and localizes it to the upper arm without further detail. Verify that the underlying neoplastic condition is documented to support the code assignment. Avoid using this code if the site is specified more precisely (e.g., right or left upper arm) or if the condition is unrelated to neoplastic disease.